Pregnancy should be a condition eligible for additional doses of COVID-19 messenger RNA vaccines

Am J Obstet Gynecol MFM. 2023 Feb;5(2):100801. doi: 10.1016/j.ajogmf.2022.100801. Epub 2022 Nov 9.

Authors

Jeremy Samuel Faust¹, Sonja A Rasmussen², Denise J Jamieson³

Affiliations

¹ Emergency Division of Health Policy and Public Health, Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (Dr Faust). Electronic address: jsfaust@gmail.com.
² Department of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD (Dr Rasmussen).
³ and Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA (Dr Jamieson).

No abstract available

MeSH terms

COVID-19 Vaccines*
COVID-19* / epidemiology
COVID-19* / prevention & control
Female
Humans
Pregnancy

Substances

COVID-19 Vaccines